Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9441388Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$1.9M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#6,168
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Boris Tabakoff as a PI. Multi-PI records show the full award amount for context.
- 4R44AA024905-07R44Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1.7Maward amount
- 3UH3DA047680-05S1UH3A novel therapeutic to ameliorate chronic pain and reduce opiate use$140Kaward amount
Award organization
Organizations that administered FY2024 awards listing Boris Tabakoff as a PI.
FY2024 award administered by Lohocla Research Corporation (CO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardLohocla Research Corporation
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6168
- 2025$2M Cumulative Funding